Dunedin-based bladder cancer detection test inventor announces the registration of its own diagnostic laboratory in Pennsylvania.
"Well done, Pacific Edge. And well done to those who supported this enterprising Dunedin-based company."
The bio-medical stock might be running hot on the potential of one cancer test but don't write the Dunedin company off as a one-trick pony.
The Dunedin-based company halted by NZX Market Supervision last month while it explained its share price rise leaps again.
The validation in the American Journal of Urology may be worth up to $100 million a year in five years for its Cxbladder test, the company says.
"...these guys have actually had their science validated by a very well respected medical journal. I say well done to the team in Dunedin."
The healthcare technology company will set up shop in the US by the end of the year.
Sign up for NBR subscriber content or email alerts
The easiest way for subscribers to stay logged in is to click the "Remember Me" option on the Member Log In box on the top right of this page.